Annual prognostic factors in chronic heart failure in patients over 80 years old

Anna Cichocka-Radwan, Małgorzata Lelonek1

  • 1Chair of Cardiology, Cardiac Surgery and Vascular Diseases Medical University of Lodz. mlelonek@poczta.fm.

Kardiologia Polska
|October 8, 2016
PubMed

Insights

In elderly patients with chronic heart failure (CHF), comorbidities like lung and vascular diseases significantly impact prognosis. Lung disease was the most aggravating factor across subgroups, highlighting its importance in predicting outcomes.

Area of Science:

  • Cardiology and Geriatrics
  • Clinical Research
  • Prognostic Factor Analysis

Background:

  • Heart failure (HF) is a leading cause of hospitalization and mortality in the elderly.
  • Chronic heart failure (CHF) presents unique challenges in octogenarians and nonagenarians.

Purpose of the Study:

  • To identify key prognostic factors for outcomes in elderly patients with chronic heart failure.
  • To analyze predictors of cardiovascular death and composite endpoints in individuals over 80 years old.

Main Methods:

  • Prospective follow-up of 197 patients over 80 hospitalized for CHF.
  • Investigation of 62 parameters including comorbidities, ECG, echocardiography, and biomarkers (hs-TnT, hs-CRP).
  • Multivariate logistic regression analysis stratified by left ventricular ejection fraction (LVEF) and glomerular filtration rate (GFR).

Main Results:

  • Independent predictors of cardiovascular death included GFR, hypertension, lung diseases, and vascular diseases.
  • Anaemia was the sole significant independent predictor for the composite endpoint (death/hospitalization for CHF exacerbation).
  • In specific subgroups, vascular and lung diseases (LVEF < 45%), haemoglobin (LVEF ≥ 45%), and red blood cell parameters (GFR < 60 mL/min) showed prognostic importance.

Conclusions:

  • Comorbidities, particularly lung disease, hold significant prognostic value for annual outcomes in elderly CHF patients.
  • Identifying specific prognostic factors in subgroups (based on LVEF and GFR) is crucial for managing geriatric heart failure.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
520
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
303
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
639
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
497